デフォルト表紙
市場調査レポート
商品コード
1693360

神経血管内治療用コイルの世界市場レポート 2025年

Neuroendovascular Coil Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
神経血管内治療用コイルの世界市場レポート 2025年
出版日: 2025年03月04日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

神経血管内治療用コイル市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.4%で18億7,000万米ドルに成長します。予測期間の成長は、神経血管症例の継続的な増加、神経インターベンションサービスの拡大、早期介入への注目、世界のヘルスケアインフラの成長、患者中心のケア動向、研究における国際共同研究などに起因しています。予測期間における主な動向としては、着脱可能な神経血管内治療用コイルの進歩、液体塞栓薬の利用増加、生体活性および生体吸収性コイルの開発、二重層コイル技術の統合、動脈瘤治療のためのフローダイバータへの注目などが挙げられます。

神経血管疾患の有病率の増加が、今後の神経血管内治療用コイル市場の成長を牽引すると予想されます。神経血管疾患は神経系に供給する血管に影響を及ぼし、しばしば神経症状や合併症を引き起こします。神経血管内コイルは、血管に挿入して異常な血管構造を遮断または安定化させ、出血やその他の合併症のリスクを低減することで、これらの疾患の治療に使用されます。例えば、2023年11月、スウェーデンの政府機関である国立保健福祉委員会(Socialstyrelsen)の報告によると、2022年には約26,800件の脳卒中が報告され、約25,100人が罹患しました。その年に脳卒中を発症した人のうち、12%が当日中に、23%が28日以内に、34%が1年以内に死亡しました。したがって、神経血管疾患の有病率の上昇が神経血管内治療用コイル市場の成長を促進しています。

ヘルスケア支出の増加は、神経血管内治療用コイル市場の成長を促進すると予想されます。ヘルスケア支出には、医療品、公衆衛生活動、管理費などのヘルスケアサービスへの支出が含まれます。この成長を促進する要因としては、人口の高齢化、医療技術の進歩、薬剤費の上昇、慢性疾患の有病率の増加などが挙げられます。医療費の増加は、神経血管内治療用コイル技術の進歩、技術革新の促進、アクセシビリティの向上、脳動脈瘤や血管障害の治療における患者の転帰の改善に寄与します。例えば、米国の学術誌*Health Affairs*によると、2024年6月、米国の国民医療費は2023年の4兆7,993億米ドルから2024年には5兆488億米ドルに増加すると予測されており、これは約2,495億米ドルの増加を反映しています。その結果、医療費の増加が神経血管内治療用コイル市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界神経血管内治療用コイルPESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界の神経血管内治療用コイル市場:成長率分析
  • 世界の神経血管内治療用コイル市場の実績:規模と成長, 2019-2024
  • 世界の神経血管内治療用コイル市場の予測:規模と成長, 2024-2029, 2034F
  • 世界神経血管内治療用コイル総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の神経血管内治療用コイル市場:製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ググリエルミ取り外し可能コイル(GDC)
  • マトリックスコイル
  • 世界の神経血管内治療用コイル市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 破裂した動脈瘤
  • 未破裂動脈瘤
  • 世界の神経血管内治療用コイル市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 腫瘍手術
  • 医学教育
  • 世界の神経血管内治療用コイル市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • 外来手術センター(ASC)
  • 脳卒中センター
  • その他のエンドユーザー
  • 世界の神経血管内治療用コイル市場、タイプ別ググリエルミ分離型コイル(GDC)のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ソフトGDC
  • 標準GDC
  • さまざまな構成の取り外し可能なGDC
  • 世界の神経血管内治療用コイル市場、マトリックスコイルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ソフトマトリックスコイル
  • コーティングマトリックスコイル
  • 取り外し可能なマトリックスコイル
  • フローダイバータマトリックスコイル

第7章 地域別・国別分析

  • 世界の神経血管内治療用コイル市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の神経血管内治療用コイル市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 神経血管内治療用コイル市場:競合情勢
  • 神経血管内治療用コイル市場:企業プロファイル
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • B. Braun Melsungen AG
  • Terumo Corporation
  • Kaneka Neurovascular USA
  • W.L. Gore & Associates Inc.
  • Cook Group Incorporated
  • Merit Medical Systems Inc.
  • MicroPort Scientific Corporation
  • Penumbra Inc.
  • MicroVention Inc.
  • Medikit Co. Ltd.
  • Minnetronix Medical Inc.
  • SurModics Inc.
  • Galen Medical Group P.C
  • Balt USA LLC
  • Acandis GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 神経血管内治療用コイル市場2029:新たな機会を提供する国
  • 神経血管内治療用コイル市場2029:新たな機会を提供するセグメント
  • 神経血管内治療用コイル市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r28600

A neuroendovascular coil is a slender wire that is introduced into blood vessels to obstruct or redirect blood flow in the affected area, facilitating clot formation and preventing further complications. This medical device is primarily employed in the treatment of cerebral aneurysms and other vascular abnormalities.

The key product types within the realm of neuroendovascular coils include Guglielmi detachable coils (GDCs) and matrix coils. Guglielmi detachable coils (GDCs) serve as medical devices utilized in endovascular procedures to address cerebral aneurysms. They work by filling the aneurysm with detachable platinum coils, promoting clotting and averting the risk of rupture. These coils find application in various indications, encompassing both ruptured and unruptured aneurysms. Additionally, GDCs are employed for diverse purposes such as tumor surgery and medical teaching, with end users including hospitals, ambulatory surgical centers (ASCs), stroke centers, and other medical facilities.

The neuroendovascular coil market research report is one of a series of new reports from The Business Research Company that provides neuroendovascular coil market statistics, including neuroendovascular coil industry global market size, regional shares, competitors with a neuroendovascular coil market share, detailed neuroendovascular coil market segments, market trends and opportunities, and any further data you may need to thrive in the neuroendovascular coil industry. This neuroendovascular coil market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuroendovascular coil market size has grown strongly in recent years. It will grow from $1.29 billion in 2024 to $1.4 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing incidence of neurovascular diseases, growing aging population, improved diagnostic technologies, expansion of neurointerventional facilities, awareness and education initiatives, regulatory approvals and standards.

The neuroendovascular coil market size is expected to see strong growth in the next few years. It will grow to $1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to continuous rise in neurovascular cases, expansion of neurointerventional services, focus on early intervention, global healthcare infrastructure growth, patient-centric care trends, international collaborations in research. Major trends in the forecast period include advancements in detachable neuroendovascular coils, rise in utilization of liquid embolics, development of bioactive and bioabsorbable coils, integration of dual-layer coil technologies, focus on flow diverters for aneurysm treatment.

The increasing prevalence of neurovascular diseases is expected to drive the growth of the neuroendovascular coil market in the future. Neurovascular diseases affect the blood vessels that supply the nervous system, often leading to neurological symptoms and complications. Neuroendovascular coils are used to treat these diseases by being inserted into blood vessels to block or stabilize abnormal blood vessel structures, thus reducing the risk of bleeding or other complications. For example, in November 2023, a report from the National Board of Health and Welfare (Socialstyrelsen), a Sweden-based government agency, revealed that in 2022, approximately 26,800 strokes were reported, affecting about 25,100 individuals. Of those who suffered a stroke that year, 12% died on the same day, 23% within 28 days, and 34% within one year. Therefore, the rising prevalence of neurovascular diseases is fueling the growth of the neuroendovascular coil market.

The increasing healthcare expenditure is expected to propel the growth of the neuroendovascular coil market moving forward. Healthcare expenditure encompasses spending on healthcare services, including medical goods, public health activities, and administrative costs. Factors driving this growth include an aging population, technological advancements in medicine, rising pharmaceutical costs, and the increasing prevalence of chronic diseases. The rising healthcare expenditure contributes to advancements in neuroendovascular coil technology, promoting innovation, enhancing accessibility, and improving patient outcomes for treating cerebral aneurysms and vascular disorders. For instance, in June 2024, according to *Health Affairs*, a US-based academic journal, national healthcare expenditure in the U.S. is projected to increase from $4,799.3 billion in 2023 to $5,048.8 billion in 2024, reflecting an increase of around $249.5 billion. As a result, the growing healthcare expenditure is driving the growth of the neuroendovascular coil market.

Major companies in the neuroendovascular coil market are directing their efforts towards the development of soft and unique-shaped coils. In neuroendovascular procedures, these coils, such as tetrahedral coils, enhance aneurysm treatment by conforming to vessel anatomy, reducing complications, and improving patient outcomes, particularly in complex cases. For example, in December 2022, Stryker Corporation, a US-based medical technology company specializing in neuroendovascular coils, introduced the Target Tetra Detachable Coil. This innovative coil combines a new tetrahedral shape and softness level, specifically designed to treat small aneurysms. It provides a 2-in-1 feature with a unique tetrahedral shape that ensures stability in wide-necked aneurysms and a soft helical tail. This shape offers strong memory while remaining soft, making it a suitable choice for treating small aneurysms.

In April 2022, Wallaby Medical LLC, a US-based medical device company focusing on developing therapies for vascular disease, completed the acquisition of Phenox GmbH for approximately $543 million. This strategic move is expected to expand Wallaby Medical's stroke treatment and prevention product pipeline, facilitating accelerated global expansion. Phenox GmbH is a Germany-based provider of neuroendovascular coils and related products.

Major companies operating in the neuroendovascular coil market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Kaneka Neurovascular USA, W.L. Gore & Associates Inc., Cook Group Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., MicroVention Inc., Medikit Co. Ltd., Minnetronix Medical Inc., SurModics Inc., Galen Medical Group P.C, Balt USA LLC, Acandis GmbH, Rapid Medical Ltd., Allium Medical Solutions Ltd., Shape Memory Medical Inc., InnoCore Pharmaceuticals BV, Wuhan HNC Technology Co. Ltd., Neural Co. Ltd., Three Rivers Medical Inc.

North America was the largest region in the neuroendovascular coil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroendovascular coil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neuroendovascular coil market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuroendovascular coil market consists of sales of push able coils, framed coils, complex-shaped coils, micro coils, macro coils, guidewires (used in conjunction with coils), and catheters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroendovascular Coil Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroendovascular coil market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuroendovascular coil ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neuroendovascular coil market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Guglielmi Detachable Coils (GDCs); Matrix Coils
  • 2) By Indication: Ruptured Aneurysm; Unruptured Aneurysm
  • 3) By Application: Tumor Surgery; Medical Teaching
  • 4) By End User: Hospitals; Ambulatory Surgical Centers (ASCs); Stroke Centers; Other End Users
  • Subsegments:
  • 1) By Guglielmi Detachable Coils (GDCs): Soft GDCs; Standard GDCs; Detachable GDCs With Various Configurations
  • 2) By Matrix Coils: Soft Matrix Coils; Coated Matrix Coils; Detachable Matrix Coils; Flow Diverter Matrix Coils
  • Companies Mentioned: Cardinal Health Inc.; Johnson & Johnson Services Inc.; Medtronic PLC; Stryker Corporation; Boston Scientific Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neuroendovascular Coil Market Characteristics

3. Neuroendovascular Coil Market Trends And Strategies

4. Neuroendovascular Coil Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Neuroendovascular Coil Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Neuroendovascular Coil PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Neuroendovascular Coil Market Growth Rate Analysis
  • 5.4. Global Neuroendovascular Coil Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Neuroendovascular Coil Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Neuroendovascular Coil Total Addressable Market (TAM)

6. Neuroendovascular Coil Market Segmentation

  • 6.1. Global Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Guglielmi Detachable Coils (GDCs)
  • Matrix Coils
  • 6.2. Global Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ruptured Aneurysm
  • Unruptured Aneurysm
  • 6.3. Global Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tumor Surgery
  • Medical Teaching
  • 6.4. Global Neuroendovascular Coil Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Stroke Centers
  • Other End Users
  • 6.5. Global Neuroendovascular Coil Market, Sub-Segmentation Of Guglielmi Detachable Coils (GDCs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Soft GDCs
  • Standard GDCs
  • Detachable GDCs With Various Configurations
  • 6.6. Global Neuroendovascular Coil Market, Sub-Segmentation Of Matrix Coils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Soft Matrix Coils
  • Coated Matrix Coils
  • Detachable Matrix Coils
  • Flow Diverter Matrix Coils

7. Neuroendovascular Coil Market Regional And Country Analysis

  • 7.1. Global Neuroendovascular Coil Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Neuroendovascular Coil Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neuroendovascular Coil Market

  • 8.1. Asia-Pacific Neuroendovascular Coil Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neuroendovascular Coil Market

  • 9.1. China Neuroendovascular Coil Market Overview
  • 9.2. China Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neuroendovascular Coil Market

  • 10.1. India Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neuroendovascular Coil Market

  • 11.1. Japan Neuroendovascular Coil Market Overview
  • 11.2. Japan Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neuroendovascular Coil Market

  • 12.1. Australia Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neuroendovascular Coil Market

  • 13.1. Indonesia Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neuroendovascular Coil Market

  • 14.1. South Korea Neuroendovascular Coil Market Overview
  • 14.2. South Korea Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neuroendovascular Coil Market

  • 15.1. Western Europe Neuroendovascular Coil Market Overview
  • 15.2. Western Europe Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neuroendovascular Coil Market

  • 16.1. UK Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neuroendovascular Coil Market

  • 17.1. Germany Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neuroendovascular Coil Market

  • 18.1. France Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neuroendovascular Coil Market

  • 19.1. Italy Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neuroendovascular Coil Market

  • 20.1. Spain Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neuroendovascular Coil Market

  • 21.1. Eastern Europe Neuroendovascular Coil Market Overview
  • 21.2. Eastern Europe Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neuroendovascular Coil Market

  • 22.1. Russia Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neuroendovascular Coil Market

  • 23.1. North America Neuroendovascular Coil Market Overview
  • 23.2. North America Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neuroendovascular Coil Market

  • 24.1. USA Neuroendovascular Coil Market Overview
  • 24.2. USA Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neuroendovascular Coil Market

  • 25.1. Canada Neuroendovascular Coil Market Overview
  • 25.2. Canada Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neuroendovascular Coil Market

  • 26.1. South America Neuroendovascular Coil Market Overview
  • 26.2. South America Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neuroendovascular Coil Market

  • 27.1. Brazil Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neuroendovascular Coil Market

  • 28.1. Middle East Neuroendovascular Coil Market Overview
  • 28.2. Middle East Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neuroendovascular Coil Market

  • 29.1. Africa Neuroendovascular Coil Market Overview
  • 29.2. Africa Neuroendovascular Coil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Neuroendovascular Coil Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Neuroendovascular Coil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neuroendovascular Coil Market Competitive Landscape And Company Profiles

  • 30.1. Neuroendovascular Coil Market Competitive Landscape
  • 30.2. Neuroendovascular Coil Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Neuroendovascular Coil Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Terumo Corporation
  • 31.3. Kaneka Neurovascular USA
  • 31.4. W.L. Gore & Associates Inc.
  • 31.5. Cook Group Incorporated
  • 31.6. Merit Medical Systems Inc.
  • 31.7. MicroPort Scientific Corporation
  • 31.8. Penumbra Inc.
  • 31.9. MicroVention Inc.
  • 31.10. Medikit Co. Ltd.
  • 31.11. Minnetronix Medical Inc.
  • 31.12. SurModics Inc.
  • 31.13. Galen Medical Group P.C
  • 31.14. Balt USA LLC
  • 31.15. Acandis GmbH

32. Global Neuroendovascular Coil Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neuroendovascular Coil Market

34. Recent Developments In The Neuroendovascular Coil Market

35. Neuroendovascular Coil Market High Potential Countries, Segments and Strategies

  • 35.1 Neuroendovascular Coil Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Neuroendovascular Coil Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Neuroendovascular Coil Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer